1-20 of 997
Myeloid Neoplasia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting bone marrow mesenchymal stromal cell–derived IL-6 to overcome acute myeloid leukemia chemoresistance

Open Access
Diyu Hou, Danni Cai, Wei Dai, Xinai Liao, Maoqing Tan, Xiaoming Zheng, Liuhuan Wang, Jingru Liu, Jin Wang, Xiaoting Wang, Qiang Fu, Huifang Huang
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4810–4824.
https://doi.org/10.1182/bloodadvances.2024015496
Published: 2025
Includes: Supplemental data
Journal Articles

Utility of IDH1/2 mutations as biomarkers for detection of measurable residual disease in acute myeloid leukemia

Open Access
Emma L. Boertjes, Christian M. Vonk, François G. Kavelaars, Marie Engvall, Sofia Nordin, Lisanne Beugelink, Melissa Rijken, Jolinda M. L. Konijnenburg, Jurjen Versluis, Bob Löwenberg, Peter J. M. Valk
Journal: Blood Advances
Blood Adv (2025) 9 (19): 4860–4869.
https://doi.org/10.1182/bloodadvances.2025016726
Published: 2025
Includes: Supplemental data
Journal Articles

Androgen receptor signaling as a new target for intervention in acute myeloid leukemia

Open Access
Fenghua Qian, Deborpita Sarkar, Brooke E Arner, Vanessa M Peduzzi, Yuting Bai, Baiye Ruan, Bei Jia, Hong Zheng, Robert F. Paulson, K. Sandeep Prabhu
Journal: Blood Advances
Blood Adv bloodadvances.2024012639.
https://doi.org/10.1182/bloodadvances.2024012639
Published: 2025
Includes: Supplemental data
Journal Articles

Statins Enhance the Efficacy of Pegylated Interferon-α2 in Philadelphia-Negative Chronic Myeloproliferative Neoplasms

Open Access
Isabella Diana Davidsen, Morten Kranker Larsen, Lea Löffler, Vibe Skov, Lasse Kjær, Trine Alma Knudsen, Anders Lindholm Sørensen, MD, Sarah Friis Christensen, Sabrina Cordua, Christina Schjellerup Eickhardt-Dalbøge, Marie Hvelplund Kristiansen, Christina Ellervik, Troels Wienecke, Hans Carl Hasselbalch
Journal: Blood Advances
Blood Adv bloodadvances.2025017016.
https://doi.org/10.1182/bloodadvances.2025017016
Published: 2025
Includes: Supplemental data
Journal Articles

Luspatercept for Patients with Lower-Risk Myelodysplastic Syndromes/Neoplasms: A Systematic Review and Meta-Analysis

Open Access
Abdulrahman Alhajahjeh, Naira Link Woite, Benjamin Rolles, Jessica M. Stempel, Alain Mina, Lourdes M Mendez, Tariq Kewan, Nikolai A. Podoltsev, Maximilian F. Stahl, Alyssa A Grimshaw, Amer M Zeidan, Jan P. Bewersdorf
Journal: Blood Advances
Blood Adv bloodadvances.2025017611.
https://doi.org/10.1182/bloodadvances.2025017611
Published: 2025
Includes: Supplemental data
Journal Articles

Platelet glycosylation in myelodysplastic syndromes correlates with disease severity

Open Access
Katelyn E. Rosenbalm, Tin Long Wong, Donny Hoang, Valerie L. Andersen, George Steinhardt, Shikan Zheng, Elizabeth A. Griffiths, Tongjun Gu, Karin M. Hoffmeister, Joseph T. Y. Lau, Michael J. Nemeth
Journal: Blood Advances
Blood Adv (2025) 9 (18): 4656–4660.
https://doi.org/10.1182/bloodadvances.2025016349
Published: 2025
Includes: Supplemental data
Journal Articles

Critical role of niche S100A8 for acute myeloid leukemia progression and hematopoiesis regeneration

Open Access
Xiaoyan Liu, Jinxian Wu, Xinqi Li, Ruiyang Pan, Li Liu, Tingting Huang, Linlu Ma, Guopeng Chen, Qian Wang, Nan Zhang, Xiqin Tong, Yuxin Tan, Hongqiang Jiang, Yuxing Liang, Min Shen, Ruihang Li, Wanyue Yin, Zhang Xian, Fuling Zhou
Journal: Blood Advances
Blood Adv bloodadvances.2024015762.
https://doi.org/10.1182/bloodadvances.2024015762
Published: 2025
Includes: Supplemental data
Journal Articles

The lncRNA ELDR suppresses tumorigenicity of AML by interfering with DNA replication and chromatin accessibility.

Open Access
Kaifee Arman, Julie Ross, Eva-Maria Piskor, Luca Lazzari, Virginie Calderon, Gaspard Reulet, Maria Vera, Edlie St. Hilaire, Hugo Wurtele, Brian T Wilhelm, Tarik Möröy
Journal: Blood Advances
Blood Adv bloodadvances.2024015427.
https://doi.org/10.1182/bloodadvances.2024015427
Published: 2025
Includes: Supplemental data
Journal Articles

Targeted GVL through HLA mismatch in double cord blood transplant

Open Access
Ann Dahlberg, Filippo Milano
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4470–4471.
https://doi.org/10.1182/bloodadvances.2025016876
Published: 2025
Journal Articles

Moving beyond the eyeball test for fitness assessment in AML

Open Access
Samuel J. Yates, Heidi D. Klepin
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4488–4490.
https://doi.org/10.1182/bloodadvances.2025016235
Published: 2025
Journal Articles

Cardiovascular Degeneration in Erdheim-Chester Disease: Prevalence, Burden, and Outcomes

Open Access
Reema Kamal Tawfiq, Grant M. Spears, Jason R. Young, Madeline Mahowald, W. Oliver Tobin, Ubenthira Patgunarajah, Gordon J Ruan, Dongni Yi, Saurabh Zanwar, Karen L. Rech, Matthew J. Koster, Aldo A. Acosta-Medina, Lucinda M Gruber, Aishwarya Ravindran, Mithun Vinod Shah, N Nora Bennani, Muhamad Alhaj Moustafa, Talal Hilal, Julio C Sartori-Valinotti, Robert Vassallo, Jay Ryu, Caroline Davidge-Pitts, Surendra Dasari, Thomas E. Witzig, Ronald S. Go, Gaurav Goyal, Jithma P. Abeykoon
Journal: Blood Advances
Blood Adv bloodadvances.2025016608.
https://doi.org/10.1182/bloodadvances.2025016608
Published: 2025
Includes: Supplemental data
Journal Articles

Symptoms, unmet needs, and quality of life in Erdheim-Chester disease: a longitudinal registry-based analysis

Open Access
Priya H. Marathe, Anne S. Reiner, Dana Bossert, Allison M. Sigler, Deanna Fournier, Kathleen Brewer, Gaurav Goyal, Thomas M. Atkinson, Jun J. Mao, Katherine S. Panageas, Eli L. Diamond
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4415–4424.
https://doi.org/10.1182/bloodadvances.2024015659
Published: 2025
Includes: Supplemental data
Journal Articles

Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer

Open Access
Ing S. Tiong, Tamia Nguyen, Chong C. Chua, Charis E. Teh, Christine Muttiah, Sarah Ftouni, John F. Seymour, Daniel Gray, Andrew W. Roberts, Sarah-Jane Dawson, Geoffrey J. Lindeman, Piers Blombery
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4391–4395.
https://doi.org/10.1182/bloodadvances.2025016063
Published: 2025
Includes: Supplemental data
Journal Articles

Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation

Open Access
Robert Wynn, Fernanda Volt, Philippe Guardiola, Srividhya Senthil, Graziana Scigliuolo, Chantal Kenzey, Barbara Cappelli, Annalisa Ruggeri, Ryad Tamouza, Vanderson Rocha, Chloe Anthias, Régis Peffault de la Tour, Katherine Clesham, Anna Castleton, Michel Schaap, Persis Amrolia, Marc Bierings, Jan J. Cornelissen, Kay Poulton, Eliane Gluckman
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4425–4435.
https://doi.org/10.1182/bloodadvances.2025015938
Published: 2025
Journal Articles

Bcl-xL inhibition potentiates interferon-induced apoptosis in MPN stem cells

Open Access
Megan J. Bywater, Rohit Haldar, Yashaswini Janardhanan, Ms, Emily Cooper, Leanne Cooper, Siu Hang Natalie Chan, Noah Jack Hayes, Victoria Ling, Jasmin M Straube, Steven W Lane
Journal: Blood Advances
Blood Adv bloodadvances.2025017242.
https://doi.org/10.1182/bloodadvances.2025017242
Published: 2025
Includes: Supplemental data
Journal Articles

The TET protein family interactor PROSER1 sustains hematopoietic stem cell function

Open Access
Elena V. Knatko, Anna Fleming, Xiang Li, Phoebe Crawley, Ieva Budriunaite, Kasper D. Rasmussen
Journal: Blood Advances
Blood Adv (2025) 9 (17): 4378–4390.
https://doi.org/10.1182/bloodadvances.2024015683
Published: 2025
Includes: Supplemental data
Journal Articles

TLR2 Agonism Suppresses Myeloid Leukemogenesis by Reprogramming Leukemia Stem Cells

Open Access
Michael E Lawler, Jennifer S Romer-Seibert, Michael S Bowman, Ramkrishna Mitra, Christine M Eischen, Robert L Bowman, Sara E Meyer
Journal: Blood Advances
Blood Adv bloodadvances.2025017018.
https://doi.org/10.1182/bloodadvances.2025017018
Published: 2025
Includes: Supplemental data
Journal Articles

Preclinical efficacy of tasquinimod-based combinations in advanced myeloproliferative neoplasms (MPN) in blastic phase

Open Access
Warren Fiskus, Lucia Masarova, Christopher P Mill, Christine Birdwell, Kaberi Das, Hanxi Hou, John A Davis, Antrix Jain, Anna Malovannaya, Taghi Manshouri, Andrew Dunbar, Surbhi Sharma, Tapan M. Kadia, Courtney D. DiNardo, Prithviraj Bose, Naveen Pemmaraju, Sanam Loghavi, Xiaoping Su, Raajit K. Rampal, Marie Törngren, Kapil N Bhalla
Journal: Blood Advances
Blood Adv bloodadvances.2025016898.
https://doi.org/10.1182/bloodadvances.2025016898
Published: 2025
Includes: Supplemental data
Journal Articles

Asciminib in late-line CML treatment

Open Access
Clinical Trials & Observations
Kendra Sweet, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4317–4318.
https://doi.org/10.1182/bloodadvances.2025016874
Published: 2025
Journal Articles

RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome

Open Access
Thomas Wiseman, Michaela Spooner, Shreyas Khanna, Kevin Hung, Carla R. Toop, Monika Kutyna, Joanne Yu, Anna Brown, Hamish Scott, Christopher Hahn, Chung Hoow Kok, Devendra Hiwase
Journal: Blood Advances
Blood Adv (2025) 9 (16): 4244–4247.
https://doi.org/10.1182/bloodadvances.2025016086
Published: 2025
Includes: Supplemental data